Researchers Reverse Juvenile Diabetes In Animal Model; Clinical Trial FDA Approved

Source: Children's Hospital of Pittsburgh
Posted: March 27, 2006

Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center researchers observed significant improvement of mice with diabetesl by a novel treatment strategy involving specific modification of the animal's own dendritic cells, thereby reversing diabetes in animal studies. The U.S. Food and Drug Administration (FDA) approved the start of a clinical trial to evaluate the safety and feasibility of the treatment (Phase 1 trial).